Hager Investment Management Services’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.8K Hold
2,178
0.02% 156
2026
Q1
$21.7K Hold
2,178
0.01% 188
2025
Q4
$18.4K Hold
2,178
0.01% 184
2025
Q3
$11.4K Buy
+2,178
New +$8.3K 0.01% 207

Other funds holding RLAY

Hager Investment Management Services's RLAY Position: Q2 2026 in Review

Hager Investment Management Services held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 2,178 shares worth $40.8K. The position accounts for 0.02% of the portfolio, ranked #156.

Hager Investment Management Services first reported a position in RLAY in Q3 2025 and has held it in 4 quarters since. 28 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Hager Investment Management Services held 2,178 shares of Relay Therapeutics worth $40.8K as of Q2 2026.
  • Hager Investment Management Services left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up 0.02% of Hager Investment Management Services's portfolio in Q2 2026, its #156 holding.
  • Hager Investment Management Services first reported a position in Relay Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 28 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.